DNA Methylation Profiles at Precancerous Stages Associated with Recurrence of Lung Adenocarcinoma

The aim of this study was to clarify the significance of DNA methylation alterations at precancerous stages of lung adenocarcinoma. Using single-CpG resolution Infinium array, genome-wide DNA methylation analysis was performed in 36 samples of normal lung tissue obtained from patients without any primary lung tumor, 145 samples of non-cancerous lung tissue (N) obtained from patients with lung adenocarcinomas, and 145 samples of tumorous tissue (T). Stepwise progression of DNA methylation alterations from normal lung tissue to non-cancerous lung tissue obtained from patients with lung adenocarcinomas, and then tumorous tissue samples, was observed at 3,270 CpG sites, suggesting that non-cancerous lung tissue obtained from patients with lung adenocarcinomas was at precancerous stages with DNA methylation alterations. At CpG sites of 2,083 genes, DNA methylation status in samples of non-cancerous lung tissue obtained from patients with lung adenocarcinomas was significantly correlated with recurrence after establishment of lung adenocarcinomas. Among such recurrence-related genes, 28 genes are normally unmethylated (average β-values based on Infinium assay in normal lung tissue samples was less than 0.2) and their DNA hypermethylation at precancerous stages was strengthened during progression to lung adenocarcinomas (ΔβT–N>0.1). Among these 28 genes, we focused on 6 for which implications in transcription regulation, apoptosis or cell adhesion had been reported. DNA hypermethylation of the ADCY5, EVX1, GFRA1, PDE9A, and TBX20 genes resulted in reduced mRNA expression in tumorous tissue samples. 5-Aza-2′-deoxycytidine treatment of lung cancer cell lines restored the mRNA expression levels of these 5 genes. Reduced mRNA expression in tumorous tissue samples was significantly correlated with tumor aggressiveness. These data suggest that DNA methylation alterations at precancerous stages determine tumor aggressiveness and outcome through silencing of specific genes.

[1]  S. Hirohashi,et al.  DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. , 1997, Cancer research.

[2]  K. Gunderson,et al.  Genome-wide DNA methylation profiling using Infinium® assay. , 2009, Epigenomics.

[3]  G. Paratcha,et al.  GDNF and GFRα1 promote formation of neuronal synapses by ligand-induced cell adhesion , 2007, Nature Neuroscience.

[4]  M. Benito,et al.  Methylation profiling in non-small cell lung cancer: clinical implications. , 2011, International journal of oncology.

[5]  P. Hainaut,et al.  An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial , 2012, Clinical Cancer Research.

[6]  Steven Piantadosi,et al.  DNA methylation markers and early recurrence in stage I lung cancer. , 2008, The New England journal of medicine.

[7]  Reiko Kurotani,et al.  Disruption of Type 5 Adenylyl Cyclase Enhances Desensitization of Cyclic Adenosine Monophosphate Signal and Increases Akt Signal With Chronic Catecholamine Stress , 2007, Circulation.

[8]  I. Wistuba,et al.  Pulmonary adenocarcinoma: A renewed entity in 2011 , 2012, Respirology.

[9]  Jing Pan,et al.  Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. , 2012, Carcinogenesis.

[10]  Y. Kanai,et al.  Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas , 2012, Carcinogenesis.

[11]  Yae Kanai,et al.  Genome‐wide DNA methylation profiles in precancerous conditions and cancers , 2010, Cancer science.

[12]  John D. Minna,et al.  Divergent Genomic and Epigenomic Landscapes of Lung Cancer Subtypes Underscore the Selection of Different Oncogenic Pathways during Tumor Development , 2011, PloS one.

[13]  A. Jimeno,et al.  Genome-wide profiling at methylated promoters in pancreatic adenocarcinoma , 2008, Cancer biology & therapy.

[14]  Stephen Lam,et al.  Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers , 2003, International journal of cancer.

[15]  Z. Estrov,et al.  Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact , 2010, Epigenetics.

[16]  H. Greulich,et al.  The genomics of lung adenocarcinoma: opportunities for targeted therapies. , 2010, Genes & cancer.

[17]  E. Brambilla,et al.  Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project. , 2009, American journal of respiratory and critical care medicine.

[18]  S. Zöchbauer-Müller,et al.  Lung cancer: From single-gene methylation to methylome profiling , 2010, Cancer and Metastasis Reviews.

[19]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[20]  Minghui Wang,et al.  TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer. , 2012, Lung cancer.

[21]  James F. Smith,et al.  Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase* , 1998, The Journal of Biological Chemistry.

[22]  N. Girard,et al.  New driver mutations in non-small-cell lung cancer. , 2011, The Lancet. Oncology.

[23]  Lin Yan,et al.  Type 5 Adenylyl Cyclase Disruption Increases Longevity and Protects Against Stress , 2007, Cell.

[24]  N. Kurimoto,et al.  [Small adenocarcinoma of the lung under long-term observation]. , 2000, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[25]  Santanu Chakraborty,et al.  Tbx20 regulation of cardiac cell proliferation and lineage specialization during embryonic and fetal development in vivo. , 2012, Developmental biology.

[26]  J. Brooks,et al.  Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence , 2012, British Journal of Cancer.

[27]  S. Lam,et al.  Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression , 2012, Genome research.

[28]  G. Kristiansen,et al.  DNA Methylation of the Homeobox Genes PITX2 and SHOX2 Predicts Outcome in Non–small-cell Lung Cancer Patients , 2012, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[29]  M. L. R. D. Christenson,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2012 .

[30]  J. Issa,et al.  Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia , 2008, Leukemia.

[31]  J. Hamilton.  Epigenetics: Principles and Practice , 2011, Digestive Diseases.

[32]  C. Hoogenraad,et al.  The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma , 2010, Oncogene.

[33]  S. Hirohashi,et al.  Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome , 2008, Carcinogenesis.

[34]  S. Hirohashi,et al.  Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues , 2006, International journal of cancer.

[35]  Boris Lenhard,et al.  Genome-wide DNA methylation profiling of non-small cell lung carcinomas , 2012, Epigenetics & Chromatin.

[36]  S. Hirohashi,et al.  Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. , 2007, Carcinogenesis.

[37]  Setsuo Hirohashi,et al.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis , 1995 .

[38]  Y. Kanai.  Alterations of DNA methylation and clinicopathological diversity of human cancers , 2008, Pathology international.

[39]  M. Aghaei,et al.  Inhibition of phosphodiestrase 9 induces cGMP accumulation and apoptosis in human breast cancer cell lines, MCF‐7 and MDA‐MB‐468 , 2012, Cell proliferation.

[40]  E. Boncinelli,et al.  Transcriptional Repression by the Human Homeobox Protein EVX1 in Transfected Mammalian Cells (*) , 1995, The Journal of Biological Chemistry.

[41]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[42]  Colin L. Stewart,et al.  Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1 , 2003, The Journal of cell biology.

[43]  C. Harrison,et al.  Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy. , 2011, Human molecular genetics.